Literature DB >> 20581807

Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast.

Felicia Marginean1, Emad A Rakha, Bernard C Ho, Ian O Ellis, Andrew H S Lee.   

Abstract

Medullary carcinomas have a better prognosis than other grade 3 mammary carcinomas, but they typically show basal-like biological features, which are associated with a poor prognosis. In this study we examined the associations and prognostic relevance of medullary histological features in a series of 165 invasive carcinomas with a basal-like phenotype: triple-negative (oestrogen receptor, progesterone receptor, HER2) and expressing at least one basal marker (CK5/6, CK14, CK17 or EGFR). The following histological features were associated with each other: prominent inflammation, anastomosing sheets, absence of fibrosis, absence of infiltrative margin and absence of gland formation. Prominent inflammation and anastomosing sheets in at least 30% of the tumour were associated with a better prognosis on univariate analysis. The combination of these two features (a simplified definition of medullary-like type) was present in 17% of tumours and was an independent prognostic factor on multivariate analysis. This simplified definition had good inter-observer reproducibility (κ=0.61) and is worthy of more detailed assessment in an unselected group of mammary carcinomas. A fibrotic focus was present in 36% of carcinomas. Only 3% of tumours with a fibrotic focus had features of medullary-like carcinomas. Fibrotic focus of greater than 30% of the tumour was associated with a poor prognosis. This study emphasizes the heterogeneity of morphology and behaviour of triple-negative basal-like carcinomas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20581807     DOI: 10.1038/modpathol.2010.123

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  17 in total

1.  Prevalence and prognostic role of triple-negative breast cancer by race: a surveillance study.

Authors:  Helen Swede; David I Gregorio; Susan H Tannenbaum; Jessica A Brockmeyer; Christine Ambrosone; Lori L Wilson; Mellisa A Pensa; Lou Gonsalves; Richard G Stevens; Carolyn D Runowicz
Journal:  Clin Breast Cancer       Date:  2011-05-12       Impact factor: 3.225

Review 2.  Therapeutic Implications of the Molecular and Immune Landscape of Triple-Negative Breast Cancer.

Authors:  Ana C Gregório; Manuela Lacerda; Paulo Figueiredo; Sérgio Simões; Sérgio Dias; João Nuno Moreira
Journal:  Pathol Oncol Res       Date:  2017-09-14       Impact factor: 3.201

3.  An in vitro-in vivo model of epithelial mesenchymal transition in triple negative breast cancer.

Authors:  Yubo Zhai; Julia Santucci-Pereira; Ricardo Lopez de Cicco; Irma H Russo; Jose Russo
Journal:  Drug Discov Today Dis Mech       Date:  2012

4.  Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified.

Authors:  A-Yong Cao; Min He; Liang Huang; Zhi-Ming Shao; Gen-Hong Di
Journal:  World J Surg Oncol       Date:  2013-04-22       Impact factor: 2.754

Review 5.  Rare Breast Cancer Subtypes.

Authors:  Sarah Jenkins; Megan E Kachur; Kamil Rechache; Justin M Wells; Stanley Lipkowitz
Journal:  Curr Oncol Rep       Date:  2021-03-23       Impact factor: 5.075

6.  Medullary breast carcinoma: a pathogenic review and immunohistochemical study using tissue microarray.

Authors:  Ming Lee; Ana Richelia Jara-Lazaro; Poh Yian Cheok; Aye Aye Thike
Journal:  Singapore Med J       Date:  2022-07       Impact factor: 3.331

7.  A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas.

Authors:  Asli Cakir; Ipek Isik Gonul; Omer Uluoglu
Journal:  Diagn Pathol       Date:  2012-10-20       Impact factor: 2.644

8.  Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas.

Authors:  Olga Kostianets; Stepan Antoniuk; Valeriy Filonenko; Ramziya Kiyamova
Journal:  Diagn Pathol       Date:  2012-11-26       Impact factor: 2.644

9.  Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.

Authors:  Anita Bane; Alicia Viloria-Petit; Dushanthi Pinnaduwage; Anna Marie Mulligan; Frances P O'Malley; Irene L Andrulis
Journal:  Breast Cancer Res Treat       Date:  2013-06-28       Impact factor: 4.872

Review 10.  Immune Responses and Risk of Triple-negative Breast Cancer: Implications for Higher Rates among African American Women.

Authors:  Joshua W Ogony; Derek C Radisky; Kathryn J Ruddy; Steven Goodison; Daniel P Wickland; Kathleen M Egan; Keith L Knutson; Yan W Asmann; Mark E Sherman
Journal:  Cancer Prev Res (Phila)       Date:  2020-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.